Compound information
- Natural Products
- ZC1308186
- Molecular Formula
- C25H42BN3O6
- Molecular Weight
- 491.316666464 g/mol
- Structure
-
- IUPAC Name
- [(1R)-1-[[(2S)-2-[[(2S)-2-(benzyloxycarbonylamino)-4-methyl-pentanoyl]amino]-4-methyl-pentanoyl]amino]-3-methyl-butyl]boronic acid
- InChI
- InChI=1S/C25H42BN3O6/c1-16(2)12-20(24(31)29-22(26(33)34)14-18(5)6)27-23(30)21(13-17(3)4)28-25(32)35-15-19-10-8-7-9-11-19/h7-11,16-18,20-22,33-34H,12-15H2,1-6H3,(H,27,30)(H,28,32)(H,29,31)/t20-,21-,22-/m0/s1
- InChI Key
- MWKOOGAFELWOCD-FKBYEOEOSA-N
- SMILES
- CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)B(O)O
- Source
- ZINC000169998630
Warheads
- Carbamate
-
- Boronic Acid
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 35 | Ring Count | 1 |
Heteroatom Count | 10 | Rotatable Bond Count | 14 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 5 |
Topological Polar Surface Area | 136.99 Å2 | LogP | 4.25 |
LogS | -4.795 | LogD | 5.17 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.11 | Pgp substrate | 0.601 |
HIA | 0.0 | F20 % | 0.94 |
F30 % | 0.0 | Caco-2 | -4.92 |
MDCK | -5.454 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.401 | PPB | 90.67 |
VD | 1.485 | Fu | 1.471 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.002 | CYP1A2 substrate | 0.629 |
CYP2A6 substrate | 0.442 | CYP2B6 substrate | 0.604 |
CYP2C19 inhibitor | 0.289 | CYP2C19 substrate | 0.949 |
CYP2C8 substrate | 0.733 | CYP2C9 inhibitor | 0.216 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.045 |
CYP2D6 substrate | 0.679 | CYP2E1 substrate | 0.202 |
CYP3A4 inhibitor | 0.04 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.767 | CL | 8.429 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.003 | Hepatotoxicity | 0.996 |
Mutagenicity | 0.122 | Rat Oral Acute Toxicity | 0.013 |
FDAMDD | 0.047 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.009 | Eye Corrosion | 0.005 |
Eye Irritation | 0.093 | Respiratory Toxicity | 0.001 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.008 | IGC50 | 3.485 |
LC50FM | 4.137 | LC50DM | 4.458 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.175 | NR-AR-LBD | 0.54 |
NR-AhR | 0.005 | NR-Aromatase | 0.96 |
NR-ER | 0.28 | NR-ER-LBD | 0.536 |
NR-PPAR-gamma | 0.881 | SR-ARE | 0.772 |
SR-ATAD5 | 0.877 | SR-HSE | 0.985 |
SR-MMP | 0.476 | SR-p53 | 0.978 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.